SEMBIOSYS GETS ALBERTA AWARD FOR PLANT BIOTECHNOLOGY.SemBioSys Genetics SemBioSys Genetics Inc. (TSX: SBS) is a biotechnology company focussed on developing pharmaceutical proteins, industrial reagents, food additives, protein-purification technologies and drug-delivery systems that take advantage of the company’s proprietary oilbody/oleosin Inc., a Calgary-based, biotechnology company, has received the Alberta Science and Technology (ASTech) Award for Innovation in Industrial Research Prize (Red Deer Red Deer, city, Canada Red Deer, city (1991 pop. 58,134), S central Alta., Canada, on the Red Deer River. It developed as a trade and service center for a region of dairying and mixed farming. and South). This award recognizes SemBioSys' efforts in pushing the frontiers of biotechnology by changing the way proteins are made. It is based on a technology proposal involving Rodrigo Siloto, a graduate student in plant molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller at the University of Calgary. Since May 2002, Rodrigo has been working in the laboratory of Maurice Moloney, Ph.D., SemBioSys founder and chief scientific officer, at the University of Calgary to increase the understanding of how oleosins are targeted to oilbodies, the natural oil storage organelle organelle /or·ga·nelle/ (or?gah-nel´) a specialized structure of a cell, such as a mitochondrion, Golgi complex, lysosome, endoplasmic reticulum, ribosome, centriole, chloroplast, cilium, or flagellum. of oilseeds. This knowledge will contribute to a further optimization optimization Field of applied mathematics whose principles and methods are used to solve quantitative problems in disciplines including physics, biology, engineering, and economics. of SemBioSys' proprietary Stratosome(tm) Biologics System. The Stratosome(tm) Biologics System provides unique production and formulation advantages, thus enabling the commercialization of protein-based drugs that otherwise would not be economically or technically viable. "It is an honour to receive this prestigious award in recognition of our leadership position in the utilization of plants as production vehicles for high value proteins," said Andrew Baum, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of SemBioSys Genetics Inc. "We fully support Rodrigo's efforts and we look forward to the results of his research that could advance our proprietary technology." About the ASTech Foundation Founded in 1989, the Alberta Science and Technology Leadership (ASTech) Foundation is a not-for-profit organization with the mission to act as a catalyst within communities of interest to promote and celebrate outstanding achievements in science and technology. About SemBioSys Calgary, Alberta-based SemBioSys is a privately held biotechnology company focused on the development of high-value protein and oilbody-based products using its proprietary oilbody-based technology ? the Stratosome(tm) Biologics System. Spun-out of the University of Calgary in 1996, the company's investors include Bay City Capital, Dow AgroSciences Dow AgroSciences LLC is a wholly owned subsidiary of the Dow Chemical Company specializing in not only agricultural chemicals such as pesticides, but also seeds and biotechnology solutions. The company is based in Indianapolis, Indiana, in the United States. Canada Inc., Ventures West, Business Development Bank of Canada The Business Development Bank of Canada is a crown corporation financial institution wholly owned by the Government of Canada. BDC plays a leadership role in delivering financial and consulting services to Canadian small business, with a particular focus on technology and exporting. , University Technologies International, Royal Bank Capital Partners and Maurice Moloney, Ph.D., scientific founder and chief scientific officer. SemBioSys has established partnerships with Syngenta, a multinational fine chemical manufacturer, and several pharmaceutical companies. For more information, call (403)250-5424 (Ext. 24) or visit http://www.sembiosys.ca. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion